Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3852 |  ANIX Anixa Biosciences, Inc. - Common Stock | 3.55 USD | -4.31% | +9.23% | -4.31% | +17.55% | 120.78 M USD | ||
| 3854 |  VANI Vivani Medical, Inc. - Common Stock | 1.36 USD | -1.45% | -1.45% | +4.62% | +9.68% | 122.68 M USD | ||
| 3855 |  GUTS Fractyl Health, Inc. - Common Stock | 0.76 USD | -2.56% | +11.76% | -3.80% | -24.00% | 120.98 M USD | ||
| 3856 |  GNLX Genelux Corporation - Common Stock | 2.58 USD | -5.15% | -3.73% | -12.84% | -31.56% | 116.73 M USD | ||
| 3858 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.87 USD | -1.14% | +7.41% | +6.10% | +40.32% | 121.27 M USD | ||
| 3864 |  INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.18 USD | 0.00% | +5.36% | +20.41% | -39.49% | 122.01 M USD | ||
| 3867 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 4.77 USD | +1.92% | +20.15% | +39.07% | -45.61% | 123.72 M USD | ||
| 3870 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 0.90 USD | -5.26% | +1.12% | -47.37% | +28.57% | 114.53 M USD | ||
| 3877 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.77 USD | -0.56% | +3.51% | -4.32% | -78.93% | 118.57 M USD | ||
| 3890 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.80 USD | -1.44% | +2.78% | +10.85% | -32.87% | 112.60 M USD | ||
| 3896 |  SEER Seer, Inc. - Class A Common Stock | 2.03 USD | 0.00% | 0.00% | +2.53% | -2.40% | 112.41 M USD | ||
| 3911 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.81 USD | -3.57% | -2.41% | +1.25% | -19.80% | 103.28 M USD | ||
| 3947 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.68 USD | +22.63% | +25.37% | +33.33% | -9.19% | 121.77 M USD | ||
| 3950 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.06 USD | -2.17% | -1.46% | +8.27% | -60.31% | 96.65 M USD | ||
| 3955 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.57 USD | -1.34% | +21.91% | +18.73% | -35.12% | 96.06 M USD | ||
| 3962 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.88 USD | +0.35% | +1.41% | -14.29% | +26.32% | 96.05 M USD | ||
| 3967 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.98 USD | -2.00% | -2.97% | +4.26% | -68.99% | 93.19 M USD | ||
| 3969 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.12 USD | -4.07% | +4.95% | +30.86% | +58.21% | 90.85 M USD | ||
| 3979 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.08 USD | -0.39% | +7.17% | +28.61% | +47.25% | 92.48 M USD | ||
| 3989 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.50 USD | -1.32% | -3.23% | -1.96% | -74.23% | 90.49 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |